Investing Ideas
/
Australian Pharmaceuticals & Biotech High Growth Potential Companies

Header cover image

Australian Pharmaceuticals & Biotech High Growth Potential Companies

UPDATED Jan 28, 2023

Companies with a Future performance score of at least 3, ordered by Future performance score.

16 companies

	Company	Last Price	7D Return	1Y Return	Market Cap	Analysts Target	Valuation	Growth	Div Yield
	OSLOncoSil Medical	AU$0.042	0%	13.5%	AU$41.8m	n/a	PS39.3x	E57.0%	n/a
	CUVClinuvel Pharmaceuticals	AU$27.97	5.0%	22.6%	AU$1.4b	AU$28.94	PE66.2x	E30.4%	0.1%
	NEUNeuren Pharmaceuticals	AU$7.96	-9.6%	144.2%	AU$1.0b	AU$8.03	PS313.6x	E100.5%	n/a
	CU6Clarity Pharmaceuticals	AU$0.84	-5.1%	14.3%	AU$218.1m	AU$1.69	PS33.8x	E82.1%	n/a
	TLXTelix Pharmaceuticals	AU$6.92	-3.1%	10.9%	AU$2.2b	AU$9.32	PS76.2x	E89.7%	n/a
	PIQProteomics International Laboratories	AU$1.15	3.6%	17.3%	AU$135.9m	AU$1.77	PS39.6x	E63.6%	n/a
	IMMImmutep	AU$0.28	-5.0%	-21.9%	AU$250.6m	AU$1.17	PS53.2x	E47.9%	n/a
	ARXAroa Biosurgery	AU$1.23	3.4%	50.0%	AU$421.8m	AU$1.51	PS9x	E88.1%	n/a
	MSBMesoblast	AU$0.94	2.2%	-13.3%	AU$696.1m	AU$1.48	PS60.9x	E75.2%	n/a
	TRJTrajan Group Holdings	AU$1.95	2.4%	-51.5%	AU$295.8m	AU$2.50	PE173.6x	E43.4%	n/a
	PARParadigm Biopharmaceuticals	AU$1.43	1.1%	-1.0%	AU$403.6m	AU$2.20	PS5094.4x	E82.2%	n/a
	MDCMedlab Clinical	AU$8.09	3.9%	-56.9%	AU$18.5m	AU$18.84	PS12x	E-10.1%	n/a
	CSLCSL	AU$294.70	-1.4%	14.4%	AU$142.1b	AU$312.52	PE44.8x	E15.2%	1.1%
	PBPProbiotec	AU$2.23	0%	-1.3%	AU$181.4m	AU$3.27	PE13.2x	E10.3%	2.5%
	KZAKazia Therapeutics	AU$0.13	4.0%	-85.9%	AU$26.6m	n/a	PS2656.4x	E59.8%	n/a
	CAUCronos Australia	AU$0.52	6.1%	92.6%	AU$289.4m	n/a	PE48.1x	S35.5%	1.9%

Page 1 of 1